Intracranial myxoid mesenchymal tumor with EWSR1 fusion is a relatively new entity first described in 2017.1 The entity has caused some controversy due to its common molecular alteration and similar histomorphology as the myxoid variant of angiomatoid fibrous histiocytoma (AFH).2 In contrast to AFH, intracranial EWSR1 myxoid mesenchymal tumors tend to lack lymphocytic cuffing and a prominent vascular component histologically. Here, EWSR1 is linked to mesenchymal cell neoplasm.